Medacta Group SA Logo

Medacta Group SA

ISIN

CH0468525222

Ticker

MOVE

Sector

Health Care

Sub-Industry

Health Care Equipment

Country

Switzerland

Year Founded

1999

About Medacta Group SA

Company Description

Medacta is an international company specializing in the design, production, and distribution of innovative orthopaedic products, as well as in the development of accompanying surgical techniques.

Established in 1999 in Switzerland, Medacta is active in joint replacement, spine surgery, and sports medicine.

Medacta is committed to improving the care and well-being of patients and maintains a strong focus on healthcare sustainability. Medacta’s innovation, forged by close collaboration with surgeon leaders globally, began with minimally invasive surgical techniques and has evolved into personalized solutions for every patient.

Through the M.O.R.E. Institute, Medacta supports surgeons with a comprehensive and tailored program dedicated to the advancement of medical education. Medacta is headquartered in Castel San Pietro, Switzerland, and operates in over 40 countries.

Served Area

Worldwide

Headquarters

Strada Regina 34
6874, Castel San Pietro
Switzerland

Insider Trades

Date Trading entity / Person Association Trade type Volume
16.04.2024 None Executive member Sell CHF 128,184.70
15.04.2024 None Executive member Sell CHF 265,729.20
12.04.2024 None Executive member Sell CHF 569,444.40
11.04.2024 None Executive member Sell CHF 105,664.80
29.06.2023 None Non-Executive member Sell CHF 1,268,759.85
21.06.2022 None Executive member Buy CHF 365,901.00
20.06.2022 None Executive member Buy CHF 110,936.75
17.06.2022 None Executive member Buy CHF 51,733.00
16.06.2022 None Executive member Buy CHF 456,598.00
15.03.2022 None Executive member Buy CHF 401,246.03

Capital Markets Information

ISIN

CH0468525222

LEI

506700P2PFU3A3DROC14

Listed Stock Exchange

SIX Swiss Exchange

Contact Investor Relations Department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.